U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Diamond-Blackfan anemia 1

Diamond-Blackfan anemia 1

Synonyms
ANEMIA, CONGENITAL ERYTHROID HYPOPLASTIC; ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND; AREGENERATIVE ANEMIA, CHRONIC CONGENITAL; BLACKFAN-DIAMOND SYNDROME; ERYTHROGENESIS IMPERFECTA; RED CELL APLASIA, PURE, HEREDITARY; RPS19-Related Diamond-Blackfan Anemia

Summary

Excerpted from the GeneReview: Diamond-Blackfan Anemia
Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.
Full text of GeneReview (by section):
Summary
Diagnosis
Clinical Characteristics
Genetically Related (Allelic) Disorders
Differential Diagnosis
Management
Genetic Counseling
Resources
Molecular Genetics
Chapter Notes
References
Authors:
Colin Sieff
view full author information

Available tests

37 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Clinical tests (37 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

  • Also known as: DBA, DBA1, LOH19CR1, S19, eS19, RPS19
    Summary: ribosomal protein S19

Clinical features

Help
Imported from Human Phenotype Ontology (HPO)

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.